Getting a Vaccine to Market

MVI places great importance on the second part of its mission — ensuring access of eventual malaria vaccines to the people who need them most and, as is so often the case, can afford them least. MVI's business development team is examining and employing a variety of strategies to prepare for the smooth introduction of malaria vaccines in the developing world.

• In negotiating with potential partners, MVI seeks to achieve a workable balance between ensuring that malaria vaccine development moves forward and ensuring that successful, appropriate vaccines will be sold at affordable prices in the public sector.
  
  
• MVI is planning to conduct a study to help the vaccine field better understand the potential public and private sector markets for malaria vaccine.
  
  
• MVI is participating in GAVI's efforts to design "pull" mechanisms that will attract potential manufacturers.